Ovarian ablation in early breast cancer: overview of the randomised trials
- 1 November 1996
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 348 (9036), 1189-1196
- https://doi.org/10.1016/s0140-6736(96)05023-4
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breastBreast Cancer Research and Treatment, 1996
- Effects of Radiotherapy and Surgery in Early Breast Cancer — An Overview of the Randomized TrialsThe New England Journal of Medicine, 1995
- The miracle of DICE therapy for acute stroke: fact or fictional product of subgroup analysis?BMJ, 1994
- Primary breast cancer: The effect of primary ovarian irradiationAnnals of Oncology, 1991
- Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial.Journal of Clinical Oncology, 1990
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerThe New England Journal of Medicine, 1988
- Chemotherapy with or without oophorectomy in high-risk premenopausal patients with operable breast cancer.Journal of Clinical Oncology, 1985
- Prophylactic oophorectomy in breast cancer therapy: A preliminary reportThe American Journal of Surgery, 1969
- Clinical trials in malignant disease: Part II—Breast cancer: Value of irradiation of the ovariesJournal of the Faculty of Radiologists, 1959
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896